Aditi Shastri, MD: Clinicians Need to ‘Come Together’ on TP53-Mutated MDS
The HemOnc Pulse
00:00
Understanding TP53 Mutations in Myelodysplastic Syndrome
This chapter discusses the impact and prognosis of TP53 mutations in myelodysplastic syndrome (MDS), highlighting the poor survival outcomes associated with these mutations. The speakers also explore treatment options and management strategies for MDS patients with TP53 mutations.
Transcript
Play full episode
